FAM160A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.592400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.573000E-01
Normal-vs-Stage2
5.718800E-01
Normal-vs-Stage3
8.486400E-01
Normal-vs-Stage4
3.475200E-01
Stage1-vs-Stage2
4.706800E-01
Stage1-vs-Stage3
7.788800E-01
Stage1-vs-Stage4
2.236000E-01
Stage2-vs-Stage3
4.052200E-01
Stage2-vs-Stage4
3.210800E-01
Stage3-vs-Stage4
1.864610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.844800E-01
Normal-vs-AfricanAmerican
3.100400E-01
Normal-vs-Asian
6.602600E-01
Caucasian-vs-AfricanAmerican
2.418400E-01
Caucasian-vs-Asian
9.707000E-01
AfricanAmerican-vs-Asian
2.463800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.540200E-01
Normal-vs-Female
6.726200E-01
Male-vs-Female
8.918000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.571000E-01
Normal-vs-Age(41-60Yrs)
4.749800E-01
Normal-vs-Age(61-80Yrs)
7.821600E-01
Normal-vs-Age(81-100Yrs)
7.935200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.851800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.525800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.964400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.349800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.561600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.507600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.792000E-01
Normal-vs-Daily Drinker
7.034000E-01
Normal-vs-Weekly Drinker
8.896200E-01
Normal-vs-Occasional Drinker
3.595600E-01
Normal-vs-Social Drinker
7.590000E-01
Non Drinker-vs-Daily Drinker
6.742400E-01
Non Drinker-vs-Weekly Drinker
4.126000E-01
Non Drinker-vs-Occasional Drinker
7.088000E-02
Non Drinker-vs-Social Drinker
7.593000E-01
Daily Drinker-vs-Weekly Drinker
3.271600E-01
Daily Drinker-vs-Occasional Drinker
1.246180E-01
Daily Drinker-vs-Social Drinker
9.859800E-01
Weekly Drinker-vs-Occasional Drinker
2.808400E-02
Weekly Drinker-vs-Social Drinker
4.165000E-01
Occasional Drinker-vs-Social Drinker
2.165600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.776000E-01
Normal-vs-Grade 2
1.278840E-01
Normal-vs-Grade 3
1.095990E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.380440E-01
Grade 1-vs-Grade 3
9.937200E-03
Grade 1-vs-Grade 4
3.776000E-01
Grade 2-vs-Grade 3
4.030300E-02
Grade 2-vs-Grade 4
1.278840E-01
Grade 3-vs-Grade 4
1.095990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.807600E-01
Normal-vs-NonDiabetic
7.072400E-01
Diabetic-vs-NonDiabetic
7.230200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.767600E-01
Normal-vs-NoPancreatitis
7.142800E-01
Pancreatitis-vs-NoPancreatitis
7.732400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.327800E-01
Normal-vs-N1
5.675600E-01
N0-vs-N1
1.677010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.474600E-01
Normal-vs-TP53-NonMutant
6.897600E-01
TP53-Mutant-vs-TP53-NonMutant
1.463160E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
